CO2019006822A2 - Composición hemostática que comprende un intercambiador de aniones y una sal de calcio - Google Patents

Composición hemostática que comprende un intercambiador de aniones y una sal de calcio

Info

Publication number
CO2019006822A2
CO2019006822A2 CONC2019/0006822A CO2019006822A CO2019006822A2 CO 2019006822 A2 CO2019006822 A2 CO 2019006822A2 CO 2019006822 A CO2019006822 A CO 2019006822A CO 2019006822 A2 CO2019006822 A2 CO 2019006822A2
Authority
CO
Colombia
Prior art keywords
calcium salt
anion exchanger
hemostatic composition
hemostatic
composition
Prior art date
Application number
CONC2019/0006822A
Other languages
English (en)
Spanish (es)
Inventor
Tamar Auerbach-Nevo
Tali Negreanu-Gilboa
Hadas Alperin
Israel Nur
Original Assignee
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL249725A external-priority patent/IL249725A0/en
Application filed by Omrix Biopharmaceuticals Ltd filed Critical Omrix Biopharmaceuticals Ltd
Publication of CO2019006822A2 publication Critical patent/CO2019006822A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
CONC2019/0006822A 2016-12-22 2019-06-26 Composición hemostática que comprende un intercambiador de aniones y una sal de calcio CO2019006822A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662437840P 2016-12-22 2016-12-22
IL249725A IL249725A0 (en) 2016-12-22 2016-12-22 A hemostatic preparation containing an anion exchanger and a calcium salt
PCT/IL2017/000009 WO2018116287A1 (en) 2016-12-22 2017-12-13 Hemostatic composition comprising an anion exchanger and a calcium salt

Publications (1)

Publication Number Publication Date
CO2019006822A2 true CO2019006822A2 (es) 2019-07-10

Family

ID=61024813

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2019/0006822A CO2019006822A2 (es) 2016-12-22 2019-06-26 Composición hemostática que comprende un intercambiador de aniones y una sal de calcio

Country Status (9)

Country Link
EP (1) EP3558326A1 (pt)
JP (2) JP2020502241A (pt)
KR (1) KR102519771B1 (pt)
CN (1) CN110121350A (pt)
AU (1) AU2017383546A1 (pt)
BR (1) BR112019012531A2 (pt)
CA (1) CA3047529A1 (pt)
CO (1) CO2019006822A2 (pt)
IL (1) IL267432B1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112675356A (zh) * 2020-12-23 2021-04-20 湖南工业大学 长期保存的止血组合物及其制备方法和长期保存的抗菌止血混合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US4923645A (en) * 1987-11-16 1990-05-08 Damon Biotech, Inc. Sustained release of encapsulated molecules
US5502042A (en) * 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
JP4159682B2 (ja) * 1998-12-22 2008-10-01 株式会社クラレ 止血材
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US20080145455A1 (en) * 2006-12-13 2008-06-19 Bedard Robert L Combination of Inorganic Hemostatic Agents with Other Hemostatic Agents
US8110208B1 (en) * 2009-03-30 2012-02-07 Biolife, L.L.C. Hemostatic compositions for arresting blood flow from an open wound or surgical site
GB201004072D0 (en) * 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
EP2575906B1 (en) * 2010-05-24 2014-12-10 University of Utah Research Foundation Reinforced adhesive complex coacervates and methods of making and using thereof
EP2776068A4 (en) * 2011-11-13 2015-05-20 Suneris Inc IN SITU CROSSLINKABLE POLYMER COMPOSITIONS AND RELATED METHODS

Also Published As

Publication number Publication date
IL267432B1 (en) 2024-03-01
KR102519771B1 (ko) 2023-04-10
JP2022166257A (ja) 2022-11-01
IL267432A (en) 2019-08-29
CN110121350A (zh) 2019-08-13
AU2017383546A1 (en) 2019-06-20
EP3558326A1 (en) 2019-10-30
KR20190099476A (ko) 2019-08-27
AU2017383546A9 (en) 2019-07-11
CA3047529A1 (en) 2018-06-28
BR112019012531A2 (pt) 2019-11-19
JP2020502241A (ja) 2020-01-23

Similar Documents

Publication Publication Date Title
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
CO2017006214A2 (es) Derivados de quinazolina utilizados para tratar el vih
CL2017002650A1 (es) Compuestos novedosos
DOP2017000038A (es) 2-(morfolin-4-il)-1,7-naftiridinas
EP3238639C0 (en) SURGICAL STAPLING SYSTEM DESIGNED TO PERFORM SELECTIVE TISSUE CUTTING
BR112017012342A2 (pt) compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos
BR112019001607A2 (pt) inibidores macrocíclicos de quinases
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201691590A1 (ru) Бензимидазол-2-амины в качестве ингибиторов midhi
BR112016023558A2 (pt) compostos úteis como imunomoduladores
CO7091182A2 (es) Inhibidores de beta-lactamasa isoxazol
BR112016015706A8 (pt) composto, uso do mesmo e composição farmacêutica
EA201591764A1 (ru) Варианты тканевого ингибитора металлопротеиназ третьего типа (timp-3), композиции и способы
DOP2018000062A (es) Piridinona dicaboxamidas para uso como inhibidores de bromodominio
CO7180201A2 (es) Inhibidores de neprilisina
BR112015023760A2 (pt) compostos e composições terapêuticas
CL2017000715A1 (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
CL2019003263A1 (es) Inhibidores de quinasa y usos de los mismos.
BR112016026518A2 (pt) Ácidos hidroxâmicos heterocíclicos como inibidores da proteína desacetilase e inibidores duais de proteína desacetilase-proteína cinase e métodos de uso dos mesmos
DK3768284T3 (da) Sammensætninger af enterococcus flagellin til anvendelse i terapi
BR112015032526A2 (pt) composições anticaspa e métodos de uso das mesmas
CL2017000587A1 (es) Derivados de tetrahidroquinolina como inhibidores de bromodominio
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina